These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35316276)

  • 1. Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy.
    Jovanovic P; Wang Y; Vit JP; Novinbakht E; Morones N; Hogg E; Tagliati M; Riera CE
    PLoS One; 2022; 17(3):e0263074. PubMed ID: 35316276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicity.
    Torrente D; Su EJ; Schielke GP; Warnock M; Mann K; Lawrence DA
    J Neuroinflammation; 2023 Mar; 20(1):56. PubMed ID: 36864439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treadmill exercise reduces α-synuclein spreading via PPARα.
    Dutta D; Paidi RK; Raha S; Roy A; Chandra S; Pahan K
    Cell Rep; 2022 Jul; 40(2):111058. PubMed ID: 35830804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-26a/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson's Disease.
    Su Y; Deng MF; Xiong W; Xie AJ; Guo J; Liang ZH; Hu B; Chen JG; Zhu X; Man HY; Lu Y; Liu D; Tang B; Zhu LQ
    Biol Psychiatry; 2019 May; 85(9):769-781. PubMed ID: 30718039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic neuron loss in mice due to increased levels of wild-type human α-Synuclein only takes place under conditions of accelerated aging.
    Perez-Villalba A; Sirerol-Piquer MS; Soriano-Cantón R; Folgado V; Pérez-Cañamás A; Kirstein M; Fariñas I; Pérez-Sánchez F
    Sci Rep; 2024 Jan; 14(1):2490. PubMed ID: 38291230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
    Goulding SR; Sullivan AM; O'Keeffe GW; Collins LM
    Parkinsonism Relat Disord; 2019 Jul; 64():194-201. PubMed ID: 31000327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra.
    Garcia-Reitboeck P; Anichtchik O; Dalley JW; Ninkina N; Tofaris GK; Buchman VL; Spillantini MG
    Exp Neurol; 2013 Oct; 248():541-5. PubMed ID: 23933574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease.
    Matschke LA; Komadowski MA; Stöhr A; Lee B; Henrich MT; Griesbach M; Rinné S; Geibl FF; Chiu WH; Koprich JB; Brotchie JM; Kiper AK; Dolga AM; Oertel WH; Decher N
    Sci Rep; 2022 Feb; 12(1):3180. PubMed ID: 35210472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline is crucial for the substantia nigra dopaminergic cell maintenance.
    Af Bjerkén S; Stenmark Persson R; Barkander A; Karalija N; Pelegrina-Hidalgo N; Gerhardt GA; Virel A; Strömberg I
    Neurochem Int; 2019 Dec; 131():104551. PubMed ID: 31542295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.